Sector Chart PharmaTher Holdings Ltd.

Equities

Market Closed - Canadian Securities Exchange Other stock markets 20:59:59 03/06/2024 BST			5-day change	1st Jan Change
0.22 ^CAD	0.00%		0.00%	-30.16%

05-15	PharmaTher's Sairiyo Submits Clinical Trial Application in Australia For Phase 1 Study of Reformulated Cepharanthine	MT
05-10	PharmaTher Assigned FDA Approval Goal Date for its New Drug Application for Ketamine	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes